A detailed history of Logan Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Logan Capital Management Inc holds 580,545 shares of PFE stock, worth $15.5 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
580,545
Previous 565,385 2.68%
Holding current value
$15.5 Million
Previous $15.8 Million 6.2%
% of portfolio
0.72%
Previous 0.71%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 06, 2024

BUY
$27.7 - $31.39 $419,932 - $475,872
15,160 Added 2.68%
580,545 $16.8 Million
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $214,760 - $251,659
-8,502 Reduced 1.48%
565,385 $15.8 Million
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $3.21 Million - $3.68 Million
123,878 Added 27.53%
573,887 $15.9 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $1 Million - $1.3 Million
-38,448 Reduced 7.87%
450,009 $13 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $1.41 Million - $1.65 Million
44,067 Added 9.92%
488,457 $16.2 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $494,880 - $572,564
13,701 Added 3.18%
444,390 $16.3 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $919,126 - $1.2 Million
23,334 Added 5.73%
430,689 $17.6 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $24,423 - $31,882
-585 Reduced 0.14%
407,355 $20.9 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $140,294 - $171,264
3,206 Added 0.79%
407,940 $17.9 Million
Q2 2022

Aug 11, 2022

SELL
$46.53 - $55.17 $451,247 - $535,038
-9,698 Reduced 2.34%
404,734 $21.2 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $2.15 Million - $2.67 Million
-47,022 Reduced 10.19%
414,432 $21.5 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $530,962 - $787,062
-12,850 Reduced 2.71%
461,454 $27.2 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $1.65 Million - $2.12 Million
42,005 Added 9.72%
474,304 $20.4 Million
Q2 2021

Aug 17, 2021

SELL
$35.91 - $40.68 $163,785 - $185,541
-4,561 Reduced 1.04%
432,299 $16.9 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $47,723 - $53,822
-1,425 Reduced 0.33%
436,860 $15.8 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $1.48 Million - $1.88 Million
-44,276 Reduced 9.18%
438,285 $16.1 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $443,833 - $520,717
-13,979 Reduced 2.82%
482,561 $17.7 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $313,910 - $380,819
10,422 Added 2.14%
496,540 $16.2 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $136,204 - $194,606
-5,039 Reduced 1.03%
486,118 $15.9 Million
Q4 2019

Feb 10, 2020

BUY
$32.92 - $37.36 $991,122 - $1.12 Million
30,107 Added 6.53%
491,157 $19.2 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $20,143 - $26,120
620 Added 0.13%
461,050 $16.6 Million
Q2 2019

Jul 24, 2019

BUY
$36.98 - $41.52 $30,434 - $34,170
823 Added 0.18%
460,430 $19.9 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $427,837 - $470,050
-11,409 Reduced 2.42%
459,607 $19.5 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $1.55 Million - $1.77 Million
-40,255 Reduced 7.87%
471,016 $20.6 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $11,547 - $14,006
335 Added 0.07%
511,271 $22.5 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $63,552 - $67,753
-1,927 Reduced 0.38%
510,936 $18.5 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $175,217 - $203,276
5,491 Added 1.08%
512,863 $18.2 Million
Q4 2017

Feb 12, 2018

SELL
$33.26 - $35.29 $573,202 - $608,187
-17,234 Reduced 3.29%
507,372 $18.4 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $37,851 - $41,697
1,221 Added 0.23%
524,606 $18.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
523,385
523,385 $17.6 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Logan Capital Management Inc Portfolio

Follow Logan Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Logan Capital Management Inc with notifications on news.